Kaleido Issuance Repayment of Debt Securities vs Net Cash Flow or Change in Cash and Cash Equivalents Analysis

KLDO -  USA Stock  

USD 5.83  0.38  6.97%

Kaleido Biosciences financial indicator trend analysis is infinitely more than just investigating Kaleido Biosciences recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Kaleido Biosciences is a good investment. Please check the relationship between Kaleido Biosciences Issuance Repayment of Debt Securities and its Net Cash Flow or Change in Cash and Cash Equivalents accounts. Please see Stocks Correlation.

Issuance Repayment of Debt Securities vs Net Cash Flow or Change in Cash and Cash Equivalents

Accounts Relationship

Issuance Repayment of Debt Securities vs Net Cash Flow or Change in Cash and Cash Equivalents

Significance: Fragmental Relationship

Issuance Repayment of Debt Securities diversification synergy
Overlapping area represents amount of trend that can be explained by analyzing historical patterns of Kaleido Biosciences Issuance Repayment of Debt Securities account and Net Cash Flow or Change in Cash and Cash Equivalents

Correlation Coefficient

0.52
Relationship DirectionPositive 
Relationship StrengthWeak

Issuance Repayment of Debt Securities

A component of Net Cash Flow from Financing representing the net cash inflow (outflow) from issuance (repayment) of debt securities.

Net Cash Flow or Change in Cash and Cash Equivalents

Principal component of the cash flow statement representing the amount of increase (decrease) in cash and cash equivalents. Includes Net Cash Flow from Operations; investing Net Cash Flow from Investing and financing Net Cash Flow from Financing for continuing and discontinued operations; and the effect of exchange rate changes on cash [NCFX].
Most indicators from Kaleido Biosciences fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Kaleido Biosciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Please see Stocks Correlation.The value of Selling General and Administrative Expense is expected to slide to about 22.8 M. The value of Issuance Purchase of Equity Shares is expected to slide to about 37.6 M
 2020 2021 (projected)
Interest Expense2.8 M2.23 M
Gross Profit877.5 K872.37 K

Kaleido Biosciences fundamental ratios Correlations

Kaleido Biosciences Account Relationship Matchups

Kaleido Biosciences Investors Sentiment

The influence of Kaleido Biosciences' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Kaleido. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.

Current Sentiment - KLDO

Kaleido Biosciences Investor Sentiment

Macroaxis portfolio users are evenly split in their trading attitude regarding investing in Kaleido Biosciences. What is your trading attitude regarding investing in Kaleido Biosciences? Are you bullish or bearish?
Bullish
Bearish
50% Bullish
50% Bearish
Skip

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Kaleido Biosciences using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please see Stocks Correlation. Note that the Kaleido Biosciences information on this page should be used as a complementary analysis to other Kaleido Biosciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.

Complementary Tools for Kaleido Stock analysis

When running Kaleido Biosciences price analysis, check to measure Kaleido Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kaleido Biosciences is operating at the current time. Most of Kaleido Biosciences' value examination focuses on studying past and present price action to predict the probability of Kaleido Biosciences' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Kaleido Biosciences' price. Additionally, you may evaluate how the addition of Kaleido Biosciences to your portfolios can decrease your overall portfolio volatility.
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Shere Portfolio
Track or share privately all of your investments from the convenience of any device
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Equity Search
Search for activelly traded equities including funds and ETFs from over 30 global markets
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Money Managers
Screen money managers from public funds and ETFs managed around the world
Go
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Go
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Go
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
The market value of Kaleido Biosciences is measured differently than its book value, which is the value of Kaleido that is recorded on the company's balance sheet. Investors also form their own opinion of Kaleido Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Kaleido Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Kaleido Biosciences' market value can be influenced by many factors that don't directly affect Kaleido Biosciences underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Kaleido Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine Kaleido Biosciences value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Kaleido Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.